Current Trends in Clinical Trials of Prodrugs

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.contributorUniversität Basel-
Autor(es): dc.contributorUnion of the Colleges of the Great Lakes (UNILAGO)-
Autor(es): dc.contributorFriedrich-Alexander-Universität Erlangen-Nürnberg-
Autor(es): dc.creatorBoreski, Diogo-
Autor(es): dc.creatorSchmid, Valentine Fabienne-
Autor(es): dc.creatorBosquesi, Priscila Longhin-
Autor(es): dc.creatordos Santos, Jean Leandro-
Autor(es): dc.creatorScarim, Cauê Benito-
Autor(es): dc.creatorReshetnikov, Viktor-
Autor(es): dc.creatorChin, Chung Man-
Data de aceite: dc.date.accessioned2025-08-21T19:22:08Z-
Data de disponibilização: dc.date.available2025-08-21T19:22:08Z-
Data de envio: dc.date.issued2025-04-29-
Data de envio: dc.date.issued2025-01-31-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.3390/ph18020210-
Fonte completa do material: dc.identifierhttps://hdl.handle.net/11449/297252-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/297252-
Descrição: dc.descriptionThe development of new drugs is a lengthy and complex process regarding its conception and ideation, passing through in silico studies, synthesis, in vivo studies, clinical trials, approval, and commercialization, with an exceptionally low success rate. The lack of efficacy, safety, and suboptimal pharmacokinetic parameters are commonly identified as significant challenges in the discovery of new drugs. To help address these challenges, various approaches have been explored in medicinal chemistry, including the use of prodrug strategies. As a well-established approach, prodrug design remains the best option for improving physicochemical properties, reducing toxicity, and increasing selectivity, all while minimizing costs and saving on biological studies. This review article aims to analyze the current advances using the prodrug approach that has allowed the advance of drug candidates to clinical trials in the last 10 years. The approaches presented here aim to inspire further molecular optimization processes and highlight the potential of this strategy to facilitate the advancement of new compounds to clinical study phases.-
Descrição: dc.descriptionLaboratory for Drug Design (LAPDESF) School of Pharmaceutical Sciences University of São Paulo State (UNESP)-
Descrição: dc.descriptionDepartement Pharmazeutische Wissenschaften Philosophisch-Naturwissenschaftliche Fakultät Universität Basel-
Descrição: dc.descriptionAdvanced Research Center in Medicine (CEPAM) School of Medicine Union of the Colleges of the Great Lakes (UNILAGO)-
Descrição: dc.descriptionDepartment Chemistry and Pharmacy Organic Chemistry II Friedrich-Alexander-Universität Erlangen-Nürnberg, Henkestrasse 42-
Descrição: dc.descriptionLaboratory for Drug Design (LAPDESF) School of Pharmaceutical Sciences University of São Paulo State (UNESP)-
Idioma: dc.languageen-
Relação: dc.relationPharmaceuticals-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectclinical trials-
Palavras-chave: dc.subjectdrug discovery-
Palavras-chave: dc.subjectprodrug design-
Palavras-chave: dc.subjectprodrugs-
Título: dc.titleCurrent Trends in Clinical Trials of Prodrugs-
Tipo de arquivo: dc.typevídeo-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.